MerTK activation triggers multiple pro-oncogenic signaling pathways, including MAPK, p38, and PI3K, which consequently make tumor cells more aggressive in terms of survival, proliferation, and resistance to apoptosis [17]. Here, MERTK is linked to neoplasm.